Skip to main content
. 2021 May 27;9(6):E943–E954. doi: 10.1055/a-1464-0809

Table 2. Endoscopic outcomes, adverse events, and clinical outcomes.

Outcomes Expert, (%) N = 96 Nonexert, (%) N = 63 P value
Endoscopic outcomes

  • Aronchick scale Excellent/good/fair

 83 (86.5)/10 (10.4)/3 (3.1) 58 (92.1)/5 (7.9)/0 (0) 0.3086

  • Cecum insertion

 92 (95.8) 62 (98.4) 0.362

  • Completion rate of insertion without expert assist

 Not applicable 62 (98.4) Not applicable

  • Time to the cecum (min), mean ± SD

 8.1 ± 5.8 11.0 ± 7.2 0.0061

  • Total procedure time (min), mean ± SD

 32.9 ± 18.9 34.5 ± 14.9 0.5761

  • SRH identification

 23 (24.0) 11 (17.5) 0.3284
Bleeding source by Colonoscopy findings

  • Diverticular (definite)

 16 (16.7) 10 (15.9) 0.8947

  • Diverticular (presumptive)

 41 (42.7) 32 (50.8) 0.317

  • Rectal ulcer

 0 (0.0) 0 (0.0) Not applicable

  • Colorectal cancer

 4 (4.2) 1 (1.6) 0.362

  • Ischemic colitis

 8 (8.3) 6 (9.5) 0.7956

  • Infectious colitis

 0 (0.0) 1 (1.6) 0.2156

  • Radiation colitis

 1 (1.0) 0 (0.0) 0.4164

  • Colonic ulcer

 0 (0.0) 2 (3.2) 0.0789

  • Nonspecific colitis

 0 (0.0) 0 (0.0) Not applicable

  • Hemorrhoid

 3 (3.1) 0 (0.0) 0.1566

  • Others

 11 (11.5) 3 (4.8) 0.145

  • Unknown

 16 (16.7) 10 (15.9) 0.8947

  • Upper gastrointestinal bleeding

 1 (1.0) 0 (0.0) 0.4164
Success rate of endoscopic treatment 19/20 (95.0) 10/10 (100) 0.472
Completion rate of successful endoscopic treatment without expert assist Not applicable 63 (100) Not applicable
Any adverse event

  • Preparation-related adverse events

 33 (34.4) 25 (39.7) 0.4965

  • Nausea/vomiting

 2 (2.1) 5 (7.9) 0.1145

  • Abdominal pain

 1 (1.0) 1 (1.6) 1.0000

  • Volume overload

 0 0 Not applicable

  • Aspiration pneumonia

 0 0 Not applicable

  • Hemorrhagic shock

 1 (1.0) 1 (1.6) 1.0000

  • Exacerbation bleeding

 32 (33.3) 21 (33.3) 1.0000

  • Ileus

 0 0 Not applicable

  • Colonoscopy related adverse events

 1 (1.0) 0 (0.0) 1.0000

  • Hemorrhagic shock

 1 (1.0) 0 (0.0) 1.0000

  • Perforation

 0 (0.0) 0 (0.0) Not applicable
SeriousaAdverse events

  • Acute myocardial infarction

 0 1 (1.6) 0.3962

  • Bacterial cellulitis

 1 (1.0) 0 1.0000
Clinical outcome N N

  • Need for additional endoscopic examinations

 96 36 (37.5) 63 18 (28.6) 0.2449

  • Need for interventional radiology

 96 1 (1.0) 63 0 (0.0) 0.4164

  • Need for surgery

 96 0 (0.0) 63 0 (0.0) Not applicable

  • Need for transfusion during hospitalization

 95 6 (6.3) 63 3 (4.8) 0.6799

  • Length of stay (day) 1

96 8.0 (6.8) 63 6.4 (3.9) 0.0449

  • 30-day rebleeding

 91 13 (14.3) 56 3 (5.4) 0.0914

  • 30-day thrombosis events

 91 0 (0.0) 56 1 (1.8) 0.2009

  • 30-day mortality

 92 0 (0.0) 56 0 (0) Not applicable

SRH, stigmata of recent hemorrhage.

1

Data are summarized as the mean (and SD).